Evidence map›Paper›PMID 24034446›Full record

ArticleTheoretical biology & medical modelling2013

Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5).

Inger Lindin, Yimingjiang Wuxiuer, Irina Kufareva, Ruben Abagyan, Ugo Moens, Ingebrigt Sylte, Aina Westrheim Ravna

Open access · hybridAbstract read
In one paragraph

Article in Theoretical biology & medical modelling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Triazolo[4,5Computational and structural biotechnology journal · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Inger LindinMedical Pharmacology and Toxicology, Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø No-9037, Norway. Aina.W.Ravna@uit.no.
Yimingjiang Wuxiuer
Irina Kufareva
Ruben Abagyan
Ugo Moens
Ingebrigt Sylte
Aina Westrheim Ravna
UiT The Arctic University of Norway · NOUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitogen-activated protein kinase-activated protein kinase 5 (MK5) is involved in one of the major signaling pathways in cells, the mitogen-activated protein kinase pathway. MK5 was discovered in 1998 by the groups of Houng Ni and Ligou New, and was found to be highly conserved throughout the vertebrates. Studies, both in vivo and in vitro, have shown that it is implicated in tumor suppression as well as tumor promotion, embryogenesis, anxiety, locomotion, cell motility and cell cycle regulation.

methodsIn order to obtain a molecular model of MK5 that can be used as a working tool for development of chemical probes, three MK5 models were constructed and refined based on three different known crystal structures of the closely related MKs; MK2 [PDB: 2OZA and PDB: 3M2W] and MK3 [PDB: 3FHR]. The main purpose of the present MK5 molecular modeling study was to identify the best suited template for making a MK5 model. The ability of the generated models to effectively discriminate between known inhibitors and decoys was analyzed using receiver operating characteristic (ROC) curves.

resultsAccording to the ROC curve analyzes, the refined model based on 3FHR was most effective in discrimination between known inhibitors and decoys.

conclusionsThe 3FHR-based MK5 model may serve as a working tool for development of chemical probes using computer aided drug design. The biological function of MK5 still remains elusive, but its role as a possible drug target may be elucidated in the near future.

Indexed as

Molecular Docking SimulationStructural Homology, ProteinAdenosine TriphosphateAmino Acid SequenceAnimalsBinding SitesCrystallography, X-RayHumansInhibitory Concentration 50Intracellular Signaling Peptides and ProteinsLigandsMolecular Sequence DataProtein Kinase InhibitorsProtein Serine-Threonine KinasesROC CurveStatic ElectricityAdenosine TriphosphateIntracellular Signaling Peptides and ProteinsLigandsMAP-kinase-activated kinase 5Protein Kinase InhibitorsProtein Serine-Threonine Kinases

Identifiers

PMID24034446
PMCPMC3848485
OpenAlexW2109950826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.